# Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

> **NCT00720577** · EARLY_PHASE1 · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 164 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Losartan
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00720577
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-07
- **Final completion:** 2007-08
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2021-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720577, "Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00720577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*